Stem Cell Breakthrough Is Like 'Turning Lead Into Gold'
By Brandon Keim,
Wired
| 11. 21. 2007
[Quotes CGS's Marcy Darnovsky]
In an unprecedented feat of biological alchemy, researchers have turned human skin cells into stem cells that hold the same medical promise as controversial embryonic stem cells.
Two teams of researchers -- one led by Kyoto University's Shinya Yamanaka, the other by the University of Wisconsin's Junying Yu -- used a virus to add four new genes to skin cells. Thus transformed, the reprogrammed cells became capable of changing into nearly any cell type in the human body. Embryonic stem cells also have this ability, and may someday be used to cure degenerative diseases, grow new organs and even replace limbs.
"It's a new era for stem cells," said Robert Lanza, chief science officer of Advanced Cell Technologies, a cloning company in California. "It's the holy grail. It's like turning lead into gold."
Scientists have hailed embryonic stem cells as one of the most promising research fields in medicine, saying they could lead to myriad therapies. But currently, many stem cells are derived from embryos, which is a lightning rod issue that crosses political and religious lines...
Related Articles
By Peter Ward, Slate | 03.30.2026
I’m in a cramped examination room at a clinic in Panama City. The lights are dim, and calming classical music plays from built-in speakers. A nurse has injected a dose of stem cells into Kenneth Scott through an IV in...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
By Emily Mullin, Wired | 03.23.2026
As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks.”
Bay Area-based R3 Bio has been quietly pitching the...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...